Report : South and Central America Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Debridement Equipment, Gauzes and Dressings, Grafts and Matrices, and Others); Wound (Traumatic and Surgical Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others); End User (Hospitals, Home Care Settings, and Others); and Country
Hospitals Segment Held Largest Share of End User in South and Central America Biofilms Treatment Market in 2019
According to a new market research study of ‘South and Central America Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Analysis by product, wound, and end-user’ the South and Central America biofilms treatment market is expected to reach US$ 330.62 million in 2027 from US$ 200.61 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020-2027. The report provides trends prevailing in the South and Central America biofilms treatment market and the factors driving market along with those that act as hindrances.
Based on the end user, the South and Central America the biofilms treatment market, is segmented into hospitals, home care settings, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The hospitals offer advanced treatment options for patients to treat chronic and hard-to-heal wounds and surgeries. Most of the surgeries are performed in hospitals, owing to continuous patient care and monitoring. Also, growing government funding for hospitals and rising hospitalization of patients drives market growth. Hospitals and specialty clinics are witnessing massive growth in number of hospitalizations across the globe. These hospitalizations are projected to drive the segment growth by 2027. For instance, according to the data published by Ontario and Alberta authorities in Canada in 2015, emergency departments witnesses around 3.7 million patients visits due to some kind of injuries. Majority injuries are related to musculoskeletal injuries. Such positive factors are likely to drive the segment growth.
The growth of this market is estimated to grow owing to key driving factors such as the rising prevalence of obesity and its co-morbidities and growing incidences of traumatic wounds across the region. However, the market is expected experiencing slow growth during the forecast period owing to the problems associated with treatment of biofilms.
B. Braun Melsungen AG, Coloplast Group, ConvaTec Group Plc are among the leading companies operating in the South and Central America biofilms treatment market.
South and Central America Biofilms Treatment Market, By Country, 2019(% share)
The report segments South and Central America Biofilms Treatment Market as Follows:
- Gauzes and Dressings
- Debridement Equipment
- Grafts and Matrices
- Traumatic and Surgical Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
By End User
- Home Care Settings
- South and Central America
- Rest of South and Central America
Contact Person: Sameer Joshi
Email Id: email@example.com